Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016;14(1):98-105.
doi: 10.2174/1570161113666150923111329.

Anti-inflammatory Strategies in Stroke: A Potential Therapeutic Target


Anti-inflammatory Strategies in Stroke: A Potential Therapeutic Target

Antonio Siniscalchi et al. Curr Vasc Pharmacol. .


Stroke is an acute condition characterized by a sudden decrease in blood flow to brain tissue, resulting in immediate deprivation of both glucose and oxygen. Different mechanisms are involved in the pathogenesis of stroke, but increasing evidence suggests that one of the processes worsening clinical outcome is inflammation with the synthesis and the release of pro-inflammatory cytokines that activate several cells contributing to the progression of brain injury. Monoclonal antibody therapy has proved useful and safe for the treatment of several systemic diseases. In contrast, the evidence is limited for the treatment of stroke. More studies are needed in order to standardize the method of treatment and establish if it is safe and effective.

Similar articles

See all similar articles

Cited by 12 articles

See all "Cited by" articles